Shopping Cart
- Remove All
- Your shopping cart is currently empty
Pitolisant is a potent and selective nonimidazole inverse agonist that targets the recombinant human histamine H3 receptor, with a Ki of 0.16 nM.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $40 | In Stock | |
10 mg | $64 | In Stock | |
25 mg | $123 | In Stock | |
50 mg | $198 | In Stock | |
100 mg | $328 | In Stock | |
500 mg | $787 | In Stock | |
1 mL x 10 mM (in DMSO) | $44 | In Stock |
Description | Pitolisant is a potent and selective nonimidazole inverse agonist that targets the recombinant human histamine H3 receptor, with a Ki of 0.16 nM. |
Targets&IC50 | H3 receptor:1.5 nM (EC50), H3 receptor:0.16 nM (Ki) |
In vitro | When stimulating [35S]-thiophosphate-labeled GTPγS binding to recombinant human H3 receptors, Pitolisant (BF2.649) acts as a competitive antagonist with a Ki value of 0.16 nM. As a reverse agonist, its EC50 value is 1.5 nM, with intrinsic activity about 50% higher than that of ciproxifan[1]. |
In vivo | Pitolisant (BF2.649) dose-dependently enhances histamine levels in the mouse brain, with an ED50 value of 1.6 mg/kg p.o. This effect persists after repeated administration for 17 days[1]. |
Alias | Tiprolisant, BF-2649, BF-2.649 |
Molecular Weight | 295.85 |
Formula | C17H26ClNO |
Cas No. | 362665-56-3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL (270.41 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.